Table 3.
Self-Reported symptoms by SARS-CoV-2 IgG status.
| Symptoms | Total n (column %) |
SARS-CoV-2 IgG Status | p-value (all data) |
|
|---|---|---|---|---|
| Positive n (row %) |
Negative n (row %) |
|||
| Total | 1743 | 95 (5.5%) | 1648 (94.5%) | |
| Fever** | 252 (14.5%) | 43 (17.1%) | 209 (82.9%) | p < 0.001†* |
| Sore throat*** | 608 (34.9%) | 33 (5.4%) | 575 (94.6%) | p < 0.001* |
| Cough | 611 (35.1%) | 45 (7.4%) | 566 (92.6%) | 0.02* |
| Runny nose | 672 (38.6%) | 32 (4.8%) | 640 (95.2%) | 0.39 |
| Shortness of breath | 280 (16.1%) | 30 (10.7%) | 250 (89.3%) | p < 0.001* |
| Chills | 362 (20.8%) | 43 (11.9%) | 319 (88.1%) | p < 0.001†* |
| Nausea/vomiting | 318 (18.2%) | 16 (5.0%) | 302 (95.0%) | 0.83 |
| Diarrhea | 409 (23.5%) | 26 (6.4%) | 383 (93.6%) | 0.43 |
| Headache | 869 (49.9%) | 49 (5.6%) | 820 (94.4%) | 0.81 |
| Rash | 73 (4.2%) | 3 (4.1%) | 70 (95.9%) | 0.79† |
| Muscle/joint pain | 566 (32.5%) | 56 (9.9%) | 510 (90.1%) | p < 0.001* |
| Loss of appetite | 285 (16.4%) | 36 (12.6%) | 249 (87.4%) | p < 0.001* |
| Loss of Smell/Taste | 116 (6.7%) | 44 (37.9%) | 72 (62.1%) | p < 0.001* |
| Fatigue | 815 (46.8%) | 64 (7.9%) | 751 (92.1%) | p < 0.001* |
| Seizures | 5 (0.3%) | 0 | 5 (100%) | 1.00† |
| Altered consciousness | 9 (0.5%) | 2 (22.2%) | 7 (77.8%) | 0.08† |
| Other neurological signs | 21 (1.2%) | 5 (23.8%) | 16 (76.2%) | 0.0045†* |
†Fisher’s Exact Test, otherwise, Chi Squared.
*Statistically significant when p-value < 0.05.
**Missing data included in analysis due to accounting for 5.2% of responses.
***Missing data included in analysis due to accounting for 5.3% of responses.
Column percentages may not always add up to 100% due to missing data. Missing data ranged from 0–1.03%.